← Evidence map

ReviewCancers2023

Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment.

Dimitrios C Ziogas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

60 papers cite it

2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37345056